Our hypothesis is that incorporating MHR and ALBI grade into one survival prediction model improves the survival prediction for patients with Metabolic Associated Fatty Liver Disease related HCC(MAFLD-HCC)
Marchiq I, Pouyssgur J
2247-C RACIAL DISPARITIES IN PREVALENCE AND INCIDENCE OF CIRRHOSIS AND EXTRAHEPATIC MANIFESTATIONS IN NONALCOHOLIC FATTY LIVER DISEASE Majd Bassam Aboona 1 , Claire Faulkner 1 , Pooja Rangan 2,3 , Vincent Chen 4 , Cheng Han Ng 5 , Daniel Q Huang 6 , Mark Dhinesh Muthiah 6 , Donghee Kim 7 , Moises Ilan Nevah Rubin 2,3 , Ma Ai Thanda Han 2,3 , Michael Fallon 2,3 and Karn Wijarnpreecha 2,3 , (1)University of Arizona College of Medicine - Phoenix, Phoenix, AZ, (2)Banner University Medical Center, (3)University of Arizona College of Medicine Phoenix, Phoenix, AZ, (4)University of Michigan Medical Center, (5)Yong Loo Lin School of Medicine, National University of Singapore, (6)National University Health System (NUHS), (7)Stanford University Medical Center Background: Nonalcoholic fatty liver disease (NAFLD) has increased in prevalence in recent years
Regenerative Medicine Approaches Regenerative therapies aim to support underlying biological processes involved in recovery rather than focusing solely on symptom management
Terminal deoxynucleotidyl transferase mediated dUTP nick-end labeling Apoptotic cells were visualized by using the TUNEL assay kit
